Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).

Kamel LaribiStéphanie PoulainLise WillemsFatiha MerabetRonan Le CallochJean R EveillardCharles HerbauxDamien Roos-WeilDriss ChaouiXavier RousselSabine TricotJehan DupuisCaroline DartigeasBenoit BareauMarie C BeneAlix Baugier de MaterreVéronique Leblond

Published in: British journal of haematology (2018)

Keyphrases

newly diagnosed
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
diffuse large b cell lymphoma
peritoneal dialysis
chronic lymphocytic leukemia
patient reported outcomes